- Home
- Publications
- Publication Search
- Publication Details
Title
Management of skin adverse reactions in oncology
Authors
Keywords
-
Journal
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
Volume -, Issue -, Pages 107815522093634
Publisher
SAGE Publications
Online
2020-07-08
DOI
10.1177/1078155220936341
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross-sectional study
- (2019) Hannah Song et al. PEDIATRIC BLOOD & CANCER
- Alopecia totalis and universalis long‐term outcomes: a review
- (2019) B. Burroway et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Hand-foot-skin reaction related to use of the multikinase inhibitor sorafenib and hard orthotics
- (2018) Ayan Kusari et al. PEDIATRIC DERMATOLOGY
- Chemotherapy-associated paronychia treated with 2% povidone–iodine: a series of cases
- (2017) Kara Capriotti et al. Cancer Management and Research
- CYTAR: A randomized clinical trial evaluating the preventive effect of doxycycline on erlotinib-induced folliculitis in non-small cell lung cancer patients.
- (2017) G. Deplanque et al. JOURNAL OF CLINICAL ONCOLOGY
- Prophylactic use of K1 cream for reducing skin toxicity during cetuximab treatment in patients with metastatic colorectal cancer (mCRC).
- (2017) J. Ocvirk et al. JOURNAL OF CLINICAL ONCOLOGY
- Vitamin K1 cream in the management of skin rash during anti-EGFR monoclonal antibody (mAb) treatment in patients with metastatic cancer: First analysis of an observational Italian study.
- (2017) C. Pinto et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted Agents: Management of Dermatologic Toxicities
- (2017) Barbara Burtness Journal of the National Comprehensive Cancer Network
- “I Lost My Image, the Image Others Know Me By”: Findings From a Hermeneutic Phenomenological Study of Patients Living With Treatment-Induced Cutaneous Toxicities
- (2016) Andreas Charalambous et al. RESEARCH IN NURSING & HEALTH
- Comparison of Skin Toxic Effects Associated With Gefitinib, Erlotinib, or Afatinib Treatment for Non–Small Cell Lung Cancer
- (2016) Kai-Lung Chen et al. JAMA Dermatology
- Regorafenib-associated hand–foot skin reaction: practical advice on diagnosis, prevention, and management
- (2015) B. McLellan et al. ANNALS OF ONCOLOGY
- Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus
- (2015) Elvio G. Russi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Management of Dermatologic Complications of Lung Cancer Therapies
- (2015) Silvina B. Pugliese et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Randomized Controlled Trial of the Prophylactic Effect of Urea-Based Cream on Sorafenib-Associated Hand-Foot Skin Reactions in Patients With Advanced Hepatocellular Carcinoma
- (2015) ZhengGang Ren et al. JOURNAL OF CLINICAL ONCOLOGY
- Body Image and the Female Adolescent Oncology Patient
- (2015) Alison Joy Burg Journal of Pediatric Oncology Nursing
- Efficacy of clindamycin phosphate and benzoyl peroxide gel (DUAC®) in the treatment of EGFR inhibitors-associated acneiform eruption
- (2015) M. Vaccaro et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Randomized, open-label trial evaluating the preventive effect of tetracycline on afatinib induced-skin toxicities in non-small cell lung cancer patients
- (2015) Oscar Arrieta et al. LUNG CANCER
- Management of regorafenib-related toxicities: a review
- (2015) Saravanan K. Krishnamoorthy et al. Therapeutic Advances in Gastroenterology
- Sorafenib-induced hand-foot syndrome in a patient of renal cell carcinoma
- (2014) Amrita Sil et al. INDIAN JOURNAL OF PHARMACOLOGY
- Topical and Systemic Antimicrobial Therapy for Venous Leg Ulcers
- (2014) Susan O’Meara et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Overview and Management of Dermatologic Events Associated with Targeted Therapies for Medullary Thyroid Cancer
- (2014) Mario E. Lacouture et al. THYROID
- The Effect of Royal Jelly on Oral Mucositis in Patients Undergoing Radiotherapy and Chemotherapy
- (2014) Özden Erdem et al. Holistic Nursing Practice
- Systemic retinoids for the chemoprevention of cutaneous squamous cell carcinoma and verrucal keratosis in a cohort of patients on BRAF inhibitors
- (2013) R. Anforth et al. BRITISH JOURNAL OF DERMATOLOGY
- Pilot Clinical Trial on the Efficacy of Prophylactic Use of Vitamin K1–Based Cream (Vigorskin) to Prevent Cetuximab-Induced Skin Rash in Patients With Metastatic Colorectal Cancer
- (2013) Francesco Pinta et al. Clinical Colorectal Cancer
- A review of the treatment options for skin rash induced by EGFR-targeted therapies: Evidence from randomized clinical trials and a metaanalysis
- (2013) Janja Ocvirk et al. Radiology and Oncology
- Treatment of capecitabine-induced hand-foot syndrome using a topical retinoid: A case report
- (2013) MASAFUMI INOKUCHI et al. Oncology Letters
- Daily baseline skin care in the prevention, treatment, and supportive care of skin toxicity in oncology patients: recommendations from a multinational expert panel
- (2013) Rene Jean Bensadoun et al. Cancer Management and Research
- Sodium Bicarbonate Solution versus Chlorhexidine Mouthwash in Oral Care of Acute Leukemia Patients Undergoing Induction Chemotherapy: A Randomized Controlled Trial
- (2012) So-Eun Choi et al. Asian Nursing Research
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- (2012) Caroline Robert et al. SEMINARS IN ONCOLOGY
- Healing acceleration in hamsters of oral mucositis induced by 5-fluorouracil with topical Calendula officinalis
- (2012) Nader Tanideh et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- Celecoxib can prevent capecitabine-related hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial
- (2011) R. X. Zhang et al. ANNALS OF ONCOLOGY
- Early detection, prevention and management of cutaneous adverse events due to sorafenib: Recommendations from the Sorafenib Working Group
- (2011) Sergio Bracarda et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Management of Skin Toxicity Associated with Cetuximab Treatment in Combination with Chemotherapy or Radiotherapy
- (2011) C. Pinto et al. ONCOLOGIST
- Clinical Presentation and Management of Hand-Foot Skin Reaction Associated with Sorafenib in Combination with Cytotoxic Chemotherapy: Experience in Breast Cancer
- (2011) P. Gomez et al. ONCOLOGIST
- Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
- (2011) Mario E. Lacouture et al. SUPPORTIVE CARE IN CANCER
- Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion
- (2010) K. Potthoff et al. ANNALS OF ONCOLOGY
- Efficacy of Vitamin E Treatment for Hand-Foot Syndrome in Patients Receiving Capecitabine
- (2010) Daigo Yamamoto et al. Breast Care
- A study of body image in long-term breast cancer survivors
- (2010) Christian A. Falk Dahl et al. CANCER
- Chemotherapy and signaling
- (2010) Tetyana V. Bagnyukova et al. CANCER BIOLOGY & THERAPY
- The hand-foot-syndrome associated with medical tumor therapy - classification and management
- (2010) Annette Degen et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- The effect of COX-2 inhibitor on capecitabine-induced hand–foot syndrome in patients with stage II/III colorectal cancer: a phase II randomized prospective study
- (2010) Rong-Xin Zhang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Placebo-Controlled Trial to Determine the Effectiveness of a Urea/Lactic Acid–Based Topical Keratolytic Agent for Prevention of Capecitabine-Induced Hand-Foot Syndrome: North Central Cancer Treatment Group Study N05C5
- (2010) Sherry L. Wolf et al. JOURNAL OF CLINICAL ONCOLOGY
- Pyridoxine Is Not Effective to Prevent Hand-Foot Syndrome Associated With Capecitabine Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study
- (2010) Yoon-Koo Kang et al. JOURNAL OF CLINICAL ONCOLOGY
- Skin Toxicity Evaluation Protocol With Panitumumab (STEPP), a Phase II, Open-Label, Randomized Trial Evaluating the Impact of a Pre-Emptive Skin Treatment Regimen on Skin Toxicities and Quality of Life in Patients With Metastatic Colorectal Cancer
- (2010) Mario E. Lacouture et al. JOURNAL OF CLINICAL ONCOLOGY
- Management of cetuximab-induced skin toxicity with the prophylactic use of topical vitamin K1 cream
- (2010) Janja Ocvirk Radiology and Oncology
- Skin care management in cancer patients: an evaluation of quality of life and tolerability
- (2010) Ann Cameron Haley et al. SUPPORTIVE CARE IN CANCER
- Evidence-Based Treatment Options for the Management of Skin Toxicities Associated with Epidermal Growth Factor Receptor Inhibitors
- (2009) Eng Hooi Tan et al. ANNALS OF PHARMACOTHERAPY
- Unanticipated toxicities from anticancer therapies: Survivors’ perspectives
- (2009) Mona Gandhi et al. SUPPORTIVE CARE IN CANCER
- Efficacy and safety of tacrolimus ointment 0·1% vs. betamethasone 17-valerate 0·1% in the treatment of chronic paronychia: an unblinded randomized study
- (2008) D. Rigopoulos et al. BRITISH JOURNAL OF DERMATOLOGY
- Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes
- (2008) Aminah Jatoi et al. CANCER
- Evolving Strategies for the Management of Hand-Foot Skin Reaction Associated with the Multitargeted Kinase Inhibitors Sorafenib and Sunitinib
- (2008) M. E. Lacouture et al. ONCOLOGIST
- Rehabilitation of Dysphagia Following Head and Neck Cancer
- (2008) Barbara R. Pauloski Physical Medicine and Rehabilitation Clinics of North America
- How corticosteroids control inflammation: Quintiles Prize Lecture 2005
- (2006) Peter J Barnes BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now